State
72,936 recalls have nationwide distribution and so reach Delaware. 3,435 additional recalls listed Delaware specifically in their distribution scope.
Of the 3,435 recalls naming Delaware we have scored against our rubric, 477 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 937 (27%) are Severe.
Which agencies issued them
These figures cover only the 3,435 recalls whose distribution notice names Delaware specifically. The 72,936 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Esaote is recalling five Endocavity ultrasonic probes, model E 3-12, because a potential weakness in the probe body may allow liquid to leak from the casing near the cable.
Rising Pharma Holding is recalling one lot of Temozolomide Capsules 5 mg after an out-of-specification result was observed during nine-month long-term stability testing.
Teva Pharmaceuticals is recalling three lots of Metoprolol Succinate Extended-Release Tablets 200 mg after the product failed dissolution specifications.
GE Healthcare is recalling Centricity Universal Viewer Zero Footprint Client because under certain workflows the patient information shown may not match the images displayed.
Olympus is recalling all lots of its Single Use Biopsy Valve, model MAJ-1218, because of the potential for rubber fragment detachment during use.
Diagnostica Stago is recalling four lots of the STA Liatest Free Protein S kit because of the potential for out-of-range results and underestimation of free protein S in normal patient plasmas.
Olympus is recalling all lots of its Single Use Biopsy Valve, model MAJ-210, because of the potential for rubber fragment detachment during use.
Mylan Pharmaceuticals is recalling two lots of Amnesteem (Isotretinoin) Capsules 40 mg after the product failed dissolution specifications.
Olympus is recalling ShockPulse-SE Lithotripsy System reusable probes after further instances of the generator remaining in a blinking phase waiting to recognize the transducer.
Acme United Corporation is recalling Med-Nap Cleansing Towelettes in bulk cases over current good manufacturing practice deviations.
Acme United Corporation is recalling First Aid Only BZK Antiseptic Towelettes in 100-count packs over current good manufacturing practice deviations.
Acme United Corporation is recalling First Aid Only BZK Antiseptic Towelettes over current good manufacturing practice deviations.
Acme United Corporation is recalling First Aid Only Hand Sanitizing Wipes over current good manufacturing practice deviations.
Acme United Corporation is recalling WP WipesPlus Hand Sanitizing Wipes over current good manufacturing practice deviations.
Acme United Corporation is recalling Med Nap BZK Antiseptic Towelettes in 100-count packs over current good manufacturing practice deviations.
Acme United Corporation is recalling Green Guard Antiseptic Wipes over current good manufacturing practice deviations.
Acme United Corporation is recalling Dynarex BZK Antiseptic Towelettes in 1,000-packet bulk packs over current good manufacturing practice deviations.
Acme United Corporation is recalling Max Packaging Antibacterial Towelettes over current good manufacturing practice deviations.
The Harvard Drug Group is recalling one lot of Midodrine Hydrochloride Tablets 5 mg because of a defective container with inadequately sealed blister packaging.
Acme United Corporation is recalling Savannah Antibacterial Towelettes over current good manufacturing practice deviations.
Acme United Corporation is recalling Dynarex Obstetrical Towelettes Cleanser over current good manufacturing practice deviations.
Acme United Corporation is recalling Medi-First Antiseptic Wipes over current good manufacturing practice deviations.
Acme United Corporation is recalling Med-Nap Cleansing Towelettes over current good manufacturing practice deviations.
Acme United Corporation is recalling Dynarex BZK Antiseptic Towelettes in 100-packet cartons over current good manufacturing practice deviations.
Harbin Jixianglong Biotech is recalling Semaglutide for prescription compounding use because process validation and bacterial endotoxin method validation were not completed before distribution.